Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pliva Inc.

Division of Teva Pharmaceutical Industries Ltd.
www.sidmaklab.com

Latest From Pliva Inc.

Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company

California Supreme Court finds Novartis liable for alleged injuries from use of a generic version of Brethine even though they occurred six years after Novartis transferred the NDA; dissenting opinion says this will expose companies to "liability in perpetuity."

Legal Issues Policy

FDA Label Decisions On Paxil Don't Deter Verdict Against GSK In Suicide Case

Chicago jury finds GSK failed to adequately warn about risk of suicidal behavior in patients over age 24 taking paroxetine; GSK argued that FDA had found no increased risk in this population.

Legal Issues FDA

Generic Relabeling Speed Could Get Supreme Court Review

Supreme Court asks the Solicitor General to weigh in on whether a state tort claim that Teva did not immediately update its generic Fosamax labeling is preempted by federal law; thousands of such suits have arisen in wake of high court’s Mensing decision.

BioPharmaceutical United States

Generic Labeling Reg Could Improve Sameness With Brand, FDA’s Woodcock Says

House hearing illustrates the strange alliances the proposed rule has produced – Republicans standing with the generic industry in opposition to the reg – and allows FDA to offer a spirited defense of the origins of the policy.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Sidmak Laboratories Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • Kurt J Orlofski, Pres. & CEO
  • Contact Info
  • Pliva Inc.
    Phone: (800) 922-0547
    72 Eagle Rock Ave.
    East Hanover, NJ 07936
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register